TARGeted IORT INTRABEAM is a useful treatment option for early stage breast cancer

TARGIT-E: Intraoperative Radiotherapy (IORT) in elderly patients with small breast cancer

The use of IORT at Universitätsmedizin Mannheim hospital

Applying the syndemic framework to cancer research for effective cancer control in LMICs

Li-Fraumeni syndrome-associated dimer-forming mutant p53 promotes transactivation-independent mitochondrial cell death

Tusamitamab ravtansine combined with SoC shows encouraging anti-tumour activity for patients with nonsquamous NSCLC

Pegargiminase-pemetrexed-platinum triplet therapy prolongs survival in non-epithelioid pleural mesothelioma

The multidisciplinary team (MDT) approach and quality of care

Breast and emerging indications for IORT

The advantages of IORT for early breast cancer treatment

CheckMate 649 biomarker analyses of NIVO + IPI vs chemo for patients with GC/GEJC/EAC

Initial results from a phase 1 dose escalation trial of E-602 shows efficacy in solid tumours